Skip to main content
Porto

PMMNG logo

  • Home
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
    • Day of Event Info
    • Course And Directions
    • Volunteers
    • Team Info
    • FAQ
    • Tribute Path
    • Partners
    • 2019 Miles For Myeloma Photos
  • Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events

  • MMRF: Maintenance Therapy for Multiple Myeloma Patients - Understanding Treatment Options
  • Patient Power: Expert Shares Keys Takeaways From 2019 International Myeloma Workshop
  • Cancer Care: Preventing Chemotherapy Induced Nausea and Vomiting
  • Patient Power: The Myeloma Empowered Thriver and Expert Chat
  • MMRF: New Drug Approval - What Does the Arrival of XPOVIO (selinexor) Mean for Multiple Myeloma Patients?
  • Cancer Care: Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation - New Treatment Approaches
  • IMF: Sorting Out the Approach to Relapse
  • Patient Power: Genetic Testing From a Myeloma Patient Perspective
  • Myeloma Crowd: Delivering Targeted Radiotherapy to Myeloma Cells – CLR 131 with Natalie Callander, MD, University of Wisconsin
  • CureTalks: Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management

LLS: Multiple Myeloma - Know Your Treatment Options

LLS logoWhat: Webcast slides and audio (1:30:04)
When: Wednesday June 19, 2019 1:00-2:00 PM ET 
Where: Web
Access Slides & Audio

Tags
event
archived
webcast
q&a
Dr. Phillip L. McCarthy
treatment
clinical trials
car-t therapy
side effects
quality of life
  • Log in to post comments